USD 675.00
2 Weeks
Recombinant Anti-Amyloid beta (aa 4-10) (Clone WO2)
Applications | ELISA, IHC, WB |
Reactivities | Human |
Conjugation | Unconjugated |
USD 675.00
2 Weeks
Recombinant Anti-Amyloid beta (aa 4-10) (Clone WO2)
Applications | ELISA, IHC, WB |
Reactivities | Human |
Conjugation | Unconjugated |
Recombinant Anti-Polysialic acid (Clone 735)
Applications | FC, IHC, IP |
Reactivities | Human, Mouse, Rat |
Conjugation | Unconjugated |
Recombinant Anti-MUC1 (Clone Mc5)
Applications | ELISA, IHC, IP, WB |
Reactivities | Human |
Conjugation | Unconjugated |
Recombinant Anti-TNF alpha (Clone D2E7 (Adalimumab))
Applications | ELISA, IF, IHC |
Reactivities | Human |
Conjugation | Unconjugated |
Modifications | This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-EGFR domain III (Clone h-R3 (Nimotuzumab))
Applications | FC, IHC |
Reactivities | Human |
Conjugation | Unconjugated |
Modifications | This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-CD8 (Clone G10-1)
Applications | FC, IF, IHC, IP |
Reactivities | Human |
Conjugation | Unconjugated |
Recombinant Anti-CD3e (Clone 898H2-6-15)
Applications | FC, IHC |
Reactivities | Pig |
Conjugation | Unconjugated |
Recombinant Anti-IL-16 (Clone 14.1)
Applications | ELISA, FC, IHC, WB |
Reactivities | Human |
Conjugation | Unconjugated |
Recombinant Anti-CD4 (Clone EDU-2 (B486))
Applications | FC, IF, IHC |
Reactivities | Human |
Conjugation | Unconjugated |
Recombinant Anti-H4 K8Ac; K12Ac; K16Ac (Clone KM-2)
Applications | ELISA, IF, IHC, WB |
Reactivities | Human |
Conjugation | Unconjugated |